גליאדל
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CARMUSTINE
Available from:
MEGAPHARM LTD
ATC code:
L01AD01
Pharmaceutical form:
פרוסה
Composition:
CARMUSTINE 7.7 MG
Administration route:
שתל
Prescription type:
מרשם נדרש
Manufactured by:
EISAI INC, USA
Therapeutic group:
CARMUSTINE
Therapeutic area:
CARMUSTINE
Therapeutic indications:
For use as an adjunct to surgery to prolong survival in patients with recurrent glioblastoma multiforme for whom surgical resection is indicated. Gliadel implant is indicated in newly-diagnosed high-grade malignant glioma patients as an adjunct to surgery and radiation. Gliadel implant is indicated for use as an adjunct to surgery in patients with Recurrent histogically proved glioblastoma multiforme for whom surgical resection is indicated.
Authorization date:
2023-05-31
